Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Third Pole is raising $12,549,903.00 in new funding. Sources indicate as part of senior management President, Basil Athenson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Third Pole

Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.

To learn more about Third Pole, visit http://www.pole3.com/

Contact:
Basil Athenson, President
800-838-1471
bathenson@pole3.com
https://www.linkedin.com/in/bill-athenson-8792b42/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved